These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 30885876)

  • 1. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology of super-enhancer reprogramming and activation in cancer.
    Zhou RW; Parsons RE
    Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-Enhancer-Driven Transcriptional Dependencies in Cancer.
    Sengupta S; George RE
    Trends Cancer; 2017 Apr; 3(4):269-281. PubMed ID: 28718439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
    Chen X; Ma Q; Shang Z; Niu Y
    NPJ Precis Oncol; 2020 Nov; 4(1):31. PubMed ID: 33299103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
    Dębek S; Juszczyński P
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-Enhancers Dysregulations in Hematological Malignancies.
    Belloucif Y; Lobry C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-enhancers in transcriptional regulation and genome organization.
    Wang X; Cairns MJ; Yan J
    Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress of super enhancer in cancer].
    Wu ZQ; Mi ZY
    Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
    Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
    Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
    Okabe A; Kaneda A
    Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer.
    Kelly MR; Wisniewska K; Regner MJ; Lewis MW; Perreault AA; Davis ES; Phanstiel DH; Parker JS; Franco HL
    Nat Commun; 2022 Jul; 13(1):4247. PubMed ID: 35869079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancers in the control of cell identity and disease.
    Hnisz D; Abraham BJ; Lee TI; Lau A; Saint-André V; Sigova AA; Hoke HA; Young RA
    Cell; 2013 Nov; 155(4):934-47. PubMed ID: 24119843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-enhancers and novel therapeutic targets in colorectal cancer.
    Liu Q; Guo L; Lou Z; Xiang X; Shao J
    Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
    Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].
    Sanda T
    Rinsho Ketsueki; 2018; 59(7):899-908. PubMed ID: 30078801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-enhancers complexes zoom in transcription in cancer.
    Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
    J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super enhancer lncRNAs: a novel hallmark in cancer.
    Song P; Han R; Yang F
    Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.